 MALVERN, Pa., Nov. 02, 2020 GLOBE NEWSWIRE -- Baudax Bio, Inc. NASDAQ:BXRX, a pharmaceutical company focused on therapeutics for acute care settings, today announced that it will report third quarter 2020 financial results on Monday, November 9, 2020. Baudaxs management team will host a conference call and audio webcast at 9:00 a.m. ET on Monday, November 9, 2020 to discuss the financial results and recent operational highlights. 